MedTrace Logo

Iron Deposits in the Pancreas by MRI Method of Dialysis Patients With Hemosiderosis Iatrogenic (ERDFP)

NCT05593068 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 185

Last updated 2022-10-25

No results posted yet for this study

Summary

Recently, a multidisciplinary scientific conference proposed to consider iron overload in dialysis patients as pathological only in the event of demonstration of radiological (in MRI), pancreatic or cardiac ferric deposits.

In this context, the aim of the proposed scientific study is to demonstrate the presence of ferric deposits in the pancreas by T2\* MRI in dialysis patients with radiological hepatic iron overload, particularly in cases of moderate and severe iron overload.

Conditions

  • Iron Deposition
  • Dialysis
  • Iatrogenic Hemosiderosis

Interventions

PROCEDURE

MRI

Pancreatic MRI

Sponsors & Collaborators

  • European Clinical Trial Experts Network

    collaborator OTHER

  • Ramsay Générale de Santé

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-04-01
Completion
2023-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593068 on ClinicalTrials.gov